¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"tumor host interaction"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
definitive host
Á¾¼÷ÁÖ
final host
Á¾¼÷ÁÖ
graft versus host reaction
ÀÌ½ÄÆí´ë¼÷ÁÖ¹ÝÀÀ
graft-versus-host disease
ÀÌ½ÄÆí´ë¼÷ÁÖº´
host
¼÷ÁÖ
host adaptation
¼÷ÁÖÀûÀÀ
host attribute
¼÷ÁÖ¼Ó¼º
host defense
¼÷ÁÖ¹æ¾î
host integration factor
¼÷ÁÖÅëÇÕÀÎÀÚ
host preference
¼÷ÁÖ¼±È£
host range
¼÷ÁÖ¹üÀ§
host selection
¼÷ÁÖ¼±ÅÃ
host specificity
¼÷ÁÖÆ¯À̼º
host susceptibility
¼÷ÁÖ°¨¼ö¼º
host-controlled modification
¼÷ÁÖÁ¶Àý¼ö½Ä
ÀÌÀü
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
carcinoid tumor
Ä«¸£½Ã³ëÀ̵åÁ¾¾ç
cystic tumor
³¶Á¾
desmoid tumor
µ¥½º¸ðÀ̵åÁ¾¾ç
endodermal sinus tumor
³»¹è¿±±¼Á¾¾ç
giant cell tumor
°Å´ë¼¼Æ÷Á¾
glomus tumor
Å丮Á¾¾ç, »ç±¸Á¾¾ç
granular cell tumor
°ú¸³¼¼Æ÷Á¾¾ç
granulosa cell tumor
°ú¸³Ãþ¼¼Æ÷Á¾¾ç
malignant tumor
¾Ç¼ºÁ¾¾ç
mesenchymal tumor
Áß°£¿±Á¾¾ç
metastatic tumor
ÀüÀÌÁ¾¾ç
neuroepithelial tumor
½Å°æ»óÇÇÁ¾¾ç
nonfunctioning tumor
ºñ±â´ÉÁ¾¾ç
occult primary tumor
Àẹ¿ø¹ßÁ¾¾ç
odontogenic tumor
Ä¡¾ÆÅ¿Á¾¾ç, Ä¡¿øÁ¾¾ç
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
abnormal host
ºñÁ¤»ó¼÷ÁÖ
accidental host
¿ì¿¬¼÷ÁÖ
alternate host
±³´ë¼÷ÁÖ
amplifier host
ÁõÆø¼÷ÁÖ
host adaptation
¼÷ÁÖÀûÀÀ
host attribute
¼÷ÁÖ¼Ó¼º
compromised host
ŸÇù¼÷ÁÖ
crustacean host
°©°¢·ù¼÷ÁÖ
definitive host
ÃÖÁ¾¼÷ÁÖ
graft-versus-host disease
À̽Ĵë¼÷ÁÖº´
host defense
¼÷ÁÖ¹æ¾î
final host
(¢¡definitive host) ÃÖÁ¾¼÷ÁÖ
host integration factor
¼÷ÁÖÅëÇÕÀÎÀÚ
graft versus host reaction
ÀÌ½ÄÆí´ë¼÷ÁÖ¹ÝÀÀ
host
¼÷ÁÖ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
antigen antibody interaction
Ç׿øÇ×ü»óÈ£¹ÝÀÀ.
antigen antibody interaction
Ç׿øÇ×ü»óÈ£¹ÝÀÀ.
antigen antibody interaction
Ç׿øÇ×ü»óÈ£¹ÝÀÀ.
antigen-antibody interaction
Ç׿ø-Ç×ü»óÈ£ÀÛ¿ë
genetic interaction
À¯ÀüÀû »óÈ£ÀÛ¿ë
heme heme interaction
Èû-Èû »óÈ£ÀÛ¿ë(¡ßÓû»íÂéÄ).
heme heme interaction
Çð-Çð »óÈ£ÀÛ¿ë(¡ßÓû»íÂéÄ).
infant-mother interaction
¿µ¾Æ-¸ð »óÈ£ÀÛ¿ë
interaction
»óÈ£ÀÛ¿ë(ßÓû»íÂéÄ).
interaction
»óÈ£ÀÛ¿ë
interaction, T-B cell
T¼¼Æ÷-B¼¼Æ÷ »óÈ£ÀÛ¿ë
interaction, T-T cell
T¼¼Æ÷°£ »óÈ£ÀÛ¿ë
interaction, primary
ÀÏÂ÷»óÈ£ÀÛ¿ë
photon interaction
±¤ÀÚ»óÈ£ÀÛ¿ë
radiation interaction
¹æ»ç¼± »óÈ£ÀÛ¿ë
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
host controlled variation
¼÷ÁÖÀÇÁ¸(±ÔÁ¦)º¯ÀÌ.
host defense
¼÷ÁÖ¹æ¾î
host factor
¼÷ÁÖÀÎÀÚ
host integration factor (HIF)
¼÷ÁÖÅëÇÕÀÎÀÚ
host range
¼÷ÁÖ¹üÀ§, ¼÷ÁÖ¿ª
host range mutation
¼÷ÁÖ¿ªº¯ÀÌ
host-controlled modification
¼÷ÁÖÁ¶Àý¼ö½Ä
host-parasite relationship
¼÷ÁÖ-±â»ýü »óÈ£°ü°è
host-parasite relationship
¼÷ÁÖ±â»ýü°ü°è
host-parasite relationships
¼÷ÁÖ ±â»ýÃæ(»ó°ü) °ü°è
host-range mutant
¼÷ÁÖ¹üÀ§º¯ÀÌÁÖ
intermediate host
Áß°£¼÷ÁÖ
mutant, host range
¼÷ÁÖ¿ª µ¹¿¬º¯ÀÌÁÖ
pneumonia,in immunocompromised host
¸é¿ª±â´ÉÀúÇϼ÷ÁÖÀÇ (Øóæ¹Ñ¦Òöî¸ù»âÖñ«¡)
relation[ship], host-parasite
¼÷ÁÖ-±â»ýü »óÈ£°ü°è
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½